162 related articles for article (PubMed ID: 7517998)
21. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.
Petersen A; Hansson O; Emgård M; Brundin P
Cell Transplant; 2000; 9(5):577-84. PubMed ID: 11144955
[TBL] [Abstract][Full Text] [Related]
22. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
23. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
[TBL] [Abstract][Full Text] [Related]
24. Single-cell suspension methodology favors survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease.
Cisbani G; Saint-Pierre M; Cicchetti F
Cell Transplant; 2014; 23(10):1267-78. PubMed ID: 23768945
[TBL] [Abstract][Full Text] [Related]
25. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
[TBL] [Abstract][Full Text] [Related]
26. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
27. Basic neural transplantation techniques. I. Dissociated cell suspension grafts of embryonic ventral mesencephalon in the adult rat brain.
Dunnett SB; Björklund A
Brain Res Brain Res Protoc; 1997 Feb; 1(1):91-9. PubMed ID: 9385053
[TBL] [Abstract][Full Text] [Related]
28. Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells.
Borlongan CV; Su TP; Wang Y
Cell Transplant; 2001; 10(1):53-8. PubMed ID: 11294472
[TBL] [Abstract][Full Text] [Related]
29. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase.
Mendez I; Hong M
Brain Res; 1997 Dec; 778(1):194-205. PubMed ID: 9462892
[TBL] [Abstract][Full Text] [Related]
30. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.
Duan WM; Rodrigues CM; Zhao LR; Steer CJ; Low WC
Cell Transplant; 2002; 11(3):195-205. PubMed ID: 12075985
[TBL] [Abstract][Full Text] [Related]
31. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
32. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
[TBL] [Abstract][Full Text] [Related]
33. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
34. Rat intrastriatal neural allografts challenged with skin allografts at different time points.
Duan WM; Cameron RM; Brundin P; Widner H
Exp Neurol; 1997 Nov; 148(1):334-47. PubMed ID: 9398476
[TBL] [Abstract][Full Text] [Related]
35. Fetal allogeneic dopaminergic cell suspension grafts in the ventricular system of the rat: characterization of transplant morphology and graft-host interactions.
Oertel J; Samii M; Walter GF
Acta Neuropathol; 2004 May; 107(5):421-7. PubMed ID: 14872256
[TBL] [Abstract][Full Text] [Related]
36. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.
Emgård M; Karlsson J; Hansson O; Brundin P
Exp Neurol; 1999 Nov; 160(1):279-88. PubMed ID: 10630212
[TBL] [Abstract][Full Text] [Related]
37. Development of human fetal substantia nigra grafts in the brain of non-immunosuppressed rats.
Bystron I; Otellin WA; Wierzba-Bobrowicz T; Dymecki J
Folia Neuropathol; 1997; 35(2):87-93. PubMed ID: 9377081
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of survival and maturation of cryopreserved dopaminergic fetal cells transplanted into rat striatum and an analysis of the host brain reaction to graft.
Kosno-Kruszewska E; Wierzba-Bobrowicz T; Ilnicki K; Lechowicz W; Dymecki J
Folia Neuropathol; 1996; 34(1):1-6. PubMed ID: 8855080
[TBL] [Abstract][Full Text] [Related]
39. Fetal porcine ventral mesencephalon graft. Determination of the optimal gestational age for implantation in parkinsonian patients.
HogenEsch RI; Koopmans J; Copray JC; van Roon WM; Kema I; Molenaar G; Go KG; Staal MJ
Exp Brain Res; 2000 Jun; 132(3):345-50. PubMed ID: 10883382
[TBL] [Abstract][Full Text] [Related]
40. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
